CSF and plasma catecholamine levels in dementia of Alzheimer type

This volume consists of 61 papers selected by the editors from a larger number presented at the 14th Congress of the Collegium Internationale Neuro-Psychopharmacologicum in Florence in June 1984. The editors have attempted to group the papers into sections, including those concerned with the affective disorders, anxiety, psychoneuroendocrinology, schizophrenia, Altzheimer's disease and psychogeriatrics. If this selection represents the best of those presented, then it has to be said that those omitted must have been of questionable value. Some of the papers included can only be described as abstracts of presentations, and others contain only the most preliminary ofresults. Several papers are about zimelidine, withdrawn from the UK market because of adverse effects many months ago. Research psychiatrists may find something of interest to them by browsing through its pages in a library, but it is unlikely to have a wide readership.